| 08:30 | 1196 | Transvascular pace-capture of aorticorenal ganglia provides a testable procedural endpoint for transcatheter renal artery denervation and identifies a novel therapeutic ablation target for denervation | Pierre QIAN (Sydney, Australia) |
|
| 08:45 | 1197 | The development and validation of a novel transcatheter microwave renal denervation system | Pierre QIAN (Sydney, Australia) |
|
| 09:00 | 1198 | Women and non-diabetic patients react more strongly to radiofrequency renal sympathetic denervation | David ZWEIKER (Vienna, Austria) |
|
| 09:15 | 1199 | Reduction in blood pressure following renal denervation for patients with differing baseline cardiovascular risk | Felix MAHFOUD (Homburg/Saar, Germany) |
|
| 09:30 | 1200 | Changes in nocturnal blood pressure post-renal denervation: comparison of treatment versus control groups in SYMPLICITY HTN-3 | Kazuomi KARIO (Shimotsuke-Shi, Japan) |
|
| 09:45 | 1201 | Cardiac function, structure, and speckle-tracking echocardiography-derived parameters after distal and conventional renal denervation: a double-blind randomized study | Tatiana RIPP (Tomsk, Russian Federation) |
|